Anti-tumor effect of recombinant plasminogen kringle 1–3 in KB cells: Histological observation and immunoprecipitation-based high performance liquid chromatography

키워드

참고문헌 (45)

1. Heinrich Sauer, "Thalidomide Inhibits Angiogenesis in Embryoid Bodies by the Generation of Hydroxyl Radicals", The American Journal of Pathology, 156(1), pp.151~158 (2000), Elsevier BV[DOI]
2. Peter Carmeliet, "Angiogenesis in cancer and other diseases", Nature, 407(6801), pp.249~257 (2000), Springer Nature[DOI]
3. Marcia G. Tonnesen, "Angiogenesis in Wound Healing", Journal of Investigative Dermatology Symposium Proceedings, 5(1), pp.40~46 (2000), Elsevier BV[DOI]
4. Gabriele Bergers, "Angiogenesis: Tumorigenesis and the angiogenic switch", Nature Reviews Cancer, 3(6), pp.401~410 (2003), Springer Nature[DOI]
5. Xiangwei Gao, "Mechanisms of action of angiogenin", Acta Biochimica et Biophysica Sinica, 40(7), pp.619~624 (2008), Oxford University Press (OUP)[DOI]
6. Ferrara N, "The biology of VEGF and its receptors", Nat Med, 9, pp.669~676 (2003)[DOI]
7. Cao Y., "Endogenous angiogenesis inhibitors: angiostatin, endostatin, and other proteolytic fragments", Prog Mol Subcell Biol, 20, pp.161~176 (1998)
8. J FOLKMAN, "Role of angiogenesis in tumor growth and metastasis", Seminars in Oncology, 29(6), pp.15~18 (2002), Elsevier BV[DOI]
9. M. E. Eichhorn, "Angiogenesis in cancer: molecular mechanisms, clinical impact", Langenbeck's Archives of Surgery, 392(3), pp.371~379 (2007), Springer Nature[DOI]
10. Yihai Cao, "Antiangiogenic cancer therapy", Seminars in Cancer Biology, 14(2), pp.139~145 (2004), Elsevier BV[DOI]
11. Eberhard F Mammen, "Angiostatin", Seminars in Thrombosis and Hemostasis, 30(1), pp.83~93 (2004), Georg Thieme Verlag KG[DOI]
12. Lucas R, "Multiple forms of angiostatin induce apoptosis in endothelial cells", Blood, 92, pp.4730~4741 (1998)
13. Claesson-Welsh L, "Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif RGD", Proc Natl Acad Sci USA, 95, pp.5579~5583 (1998)
14. Kirsch M, "Angiostatin suppresses malignant glioma growth in vivo", Cancer Res, 58, pp.4654~4659 (1998)
15. Lannutti BJ, "Human angiostatin inhibits murine hemangioendothelioma tumor growth in vivo", Cancer Res, 57, pp.5277~5280 (1997)
16. Yokoyama Y, "Synergy between angiostatin and endostatin:inhibition of ovarian cancer growth", Cancer Res, 60, pp.2190~2196 (2000)
17. Frank A. Scappaticci, "Combination Angiostatin and Endostatin Gene Transfer Induces Synergistic Antiangiogenic Activity in Vitro and Antitumor Efficacy in Leukemia and Solid Tumors in Mice", Molecular Therapy, 3(2), pp.186~196 (2001), Elsevier BV[DOI]
18. Ponnazhagan S, "Adeno-associated virus 2-mediated antiangiogenic cancer gene therapy:long-term efficacy of a vector encoding angiostatin and endostatin over vectors encoding a single factor", Cancer Res, 64, pp.1781~1787 (2004)[DOI]
19. Indraccolo S, "Effects of angiostatin gene transfer on functional properties and in vivo growth of Kaposi's sarcoma cells", Cancer Res, 61, pp.5441~5446 (2001)
20. G. Bergers, "Effects of Angiogenesis Inhibitors on Multistage Carcinogenesis in Mice", Science, 284(5415), pp.808~812 (1999), American Association for the Advancement of Science (AAAS)[DOI]
21. Kurup A, "Recombinant human angiostatin (rhAngiostatin) in combination with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer: a phase II study from Indiana University", Ann Oncol, 17, pp.97~103 (2006)[DOI]
22. Beerepoot LV, "Recombinant human angiostatin by twice-daily subcutaneous injection in advanced cancer:a pharmacokinetic and long-term safety study", Clin Cancer Res, 9, pp.4025~4033 (2003)
23. Weon-Kyoo You, "Characterization and biological activities of recombinant human plasminogen kringle 1–3 produced in Escherichia coli", Protein Expression and Purification, 36(1), pp.1~10 (2004), Elsevier BV[DOI]
24. Joe YA, "Inhibition of human malignant glioma growth in vivo by human recombinant plasminogen kringles 1-3", Int J Cancer, 82, pp.694~699 (1999)
25. Shin SH, "Recombinant kringle 1-3 of plasminogen inhibits rabbit corneal angiogenesis induced by angiogenin", Cornea, 19, pp.212~217 (2000)
26. Jung Hwan Kim, "The inhibitory effects of recombinant plasminogen kringle 1-3 on the neovascularization of rabbit cornea induced by angiogenin, bFGF and VEGF", Experimental & Molecular Medicine, 31(4), pp.203~209 (1999), Springer Nature[DOI]
27. Soung Min Kim, "Differential protein expression in the secretory fluids of maxillary sinusitis and maxillary retention cyst", European Archives of Oto-Rhino-Laryngology, 274(1), pp.215~222 (2017), Springer Nature[DOI]
28. G. Carlsson, "Estimation of liver tumor volume using different formulas?An experimental study in rats", Journal of Cancer Research and Clinical Oncology, 105(1), pp.20~23 (1983), Springer Nature[DOI]
29. Raffaella Dell'Eva, "Inhibition of Tumor Angiogenesis by Angiostatin: From Recombinant Protein to Gene Therapy", Endothelium, 9(1), pp.3~10 (2009), Informa UK Limited[DOI]
30. Rüde E, "Production of IgG antibodies and enhanced response of nude mice to DNPAE-dextran", J Immunol, 116, pp.527~533 (1976)
31. Kathleen Hillman, "A polymer containing a repeating peptide sequence can stimulate T-cell-independent IgG antibody production in Vivo", Cellular Immunology, 134(1), pp.1~13 (1991), Elsevier BV[DOI]
32. T Bachelot, "Autoantibodies to endostatin in patients with breast cancer: correlation to endostatin levels and clinical outcome", British Journal of Cancer, 94(7), pp.1066~1070 (2006), Springer Nature[DOI]
33. George-Lucian Moldovan, "PCNA, the Maestro of the Replication Fork", Cell, 129(4), pp.665~679 (2007), Elsevier BV[DOI]
34. Jörn Bullwinkel, "Ki-67 protein is associated with ribosomal RNA transcription in quiescent and proliferating cells", Journal of Cellular Physiology, 206(3), pp.624~635 (2006), Wiley-Blackwell[DOI]
35. Kanae Oda, "A comprehensive pathway map of epidermal growth factor receptor signaling", Molecular Systems Biology, 1(1), pp.E1~E17 (2005), Wiley-Blackwell[DOI]
36. A. C. Mita, "Survivin: Key Regulator of Mitosis and Apoptosis and Novel Target for Cancer Therapeutics", Clinical Cancer Research, 14(16), pp.5000~5005 (2008), American Association for Cancer Research (AACR)[DOI]
37. H. Myoung, "Correlation of proliferative markers (Ki-67 and PCNA) with survival and lymph node metastasis in oral squamous cell carcinoma: a clinical and histopathological analysis of 113 patients", International Journal of Oral and Maxillofacial Surgery, 35(11), pp.1005~1010 (2006), Elsevier BV[DOI]
38. Wong DT, "Epidermal growth factor receptor (EGFR) biology and human oral cancer", Histol Histopathol, 14, pp.491~500 (1999)
39. Jean-Christophe Bourdon, "Uncovering the role of p53 splice variants in human malignancy: a clinical perspective", OncoTargets and Therapy, pp.57~ (2013), Dove Medical Press Ltd.[DOI]
40. Andrei L. Gartel, "Lost in Transcription: p21 Repression, Mechanisms, and Consequences: Figure 1.", Cancer Research, 65(10), pp.3980~3985 (2005), American Association for Cancer Research (AACR)[DOI]
41. Murphree L, "Retinoblastoma: clues to human oncogenesis", Science, 223, pp.1028~1034 (1984)
42. Shou Waga, "The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA", Nature, 369(6481), pp.574~578 (1994), Springer Nature[DOI]
43. A. TELLO-MONTOLIU, "Angiogenin: a review of the pathophysiology and potential clinical applications", Journal of Thrombosis and Haemostasis, 4(9), pp.1864~1874 (2006), Wiley-Blackwell[DOI]
44. Shibuya M, "Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases", J Biochem, 153, pp.13~19 (2013)[DOI]
45. S. M. Albelda, "Molecular and cellular properties of PECAM-1 (endoCAM", CD31): a novel vascular cell-cell adhesion molecule, 1991, pp.114(5), 1059~1068[DOI]

관련 논문AI추천